Survivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligand

James R. Patrinely, Arissa Young, Henry T. Quach, Grant R. Williams, Fei Ye, Run Fan, Leora Horn, Kathryn E. Beckermann, Erin A. Gillaspie, Jeffrey A. Sosman, Debra L. Friedman, Javid J. Moslehi, Douglas B. Johnson